SCHEMBL2656911

SCHEMBL2656911

Cc1ncccc1Oc1cc(SCCO)cnc1Nc1nc(C(O)CO)ns1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22808 1.00 GCK (0.51) GCK
SCHEMBL12990086 0.94 GCK (0.52) GCK
SCHEMBL21806 0.94 GCK (0.52) GCK
Hydrochloric Acid SCHEMBL2658489 0.94 GCK (0.51) GCK
Hydrochloric Acid SCHEMBL3008820 0.94 GCK (0.51) GCK
SCHEMBL12989546 0.92 GCK (0.58) GCK
SCHEMBL22945 0.92 GCK (0.58) GCK
Hydrochloric Acid SCHEMBL2661916 0.91 GCK (0.57) GCK
SCHEMBL12989110 0.89 GCK (0.53) GCK
SCHEMBL2661849 0.89 GCK (0.53) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2209778-A1 PYRIDIN-2 -YL-AMINO-I, 2, 4 -THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS Array Biopharma, Inc. (US) 2010-07-28 EP disclosed
WO-2009042435-A1 PYRIDIN-2 -YL-AMINO-I, 2, 4 -THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS ARRAY BIOPHARMA INC. (US) 2009-04-02 WO disclosed